Kyowa Hakko Kirin expands European presence as ProStrakan acquires Archimedes
This article was originally published in Scrip
Executive Summary
Kyowa Hakko Kirin, via its subsidiary ProStrakan, is acquiring the UK's Archimedes Pharma for £230m ($393m) in a move that will significantly expand ProStrakan's reach across Europe.